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ETHNIC DIFFERENCES IN INTRAMYOCELLULAR LIPID LEVELS AND
INSULIN RESISTANCE IN OBESE CHILDREN AND ADOLESCENTS.

David Liska, Ram Weiss, Sara E. Taksali, James Dziura, and Sonia Caprio. Department
of Pediatrics, the General Clinical Research Center, Yale University School of Medicine,
New Haven, CT
The prevalence of insulin resistance and type 2 diabetes mellitus (T2DM) in obese
children and adolescents is growing at an alarming rate, especially in ethnic minorities. It
is not clear whether young people of different ethnic backgrounds vary in their metabolic
response to excessive adiposity. Differences in lipid partitioning in the abdominal fat
compartments have been observed among different ethnic groups. The aim of this study
was to evaluate whether there are ethnic differences in intramyocellular lipid (IMCL)
levels that are related to differences in insulin sensitivity. Eighty-two obese children and
adolescents underwent 1) 1H nuclear magnetic resonance (NMR) spectroscopy to noninvasively quantify IMCL levels in their soleus muscle, 2) an oral glucose tolerance test
and (in a subset of subjects) a euglycemic-hyperinsulinemic clamp to assess insulin
sensitivity, 3) a dual-energy X-ray absorptiometry (DEXA) scan to measure total percent
body fat, and 4) magnetic resonance imaging to measure abdominal fat distribution.
IMCL levels in Hispanic children and adolescents (1.50 ± 0.64%) were significantly
greater than in their Caucasian (1.19 ± 0.40%) and African-American (1.09 ± 0.49%)
peers. Visceral fat was significantly lower in African Americans (42.7 ± 18.8cm2) and
were similar in Caucasians (70.9 ± 27.5cm2) and Hispanics (77.3 ± 41.9cm2). The three
groups were not different with respect to insulin sensitivity. For the entire cohort, IMCL
levels were inversely related to insulin sensitivity. There was a significant correlation

between visceral fat and insulin resistance in Hispanics and Caucasians but not in African
Americans. In conclusion, these data suggest that there are significant ethnic differences
in lipid partitioning in both the muscle and abdominal compartment. These findings may
explain ethnic differences in insulin sensitivity and further the understanding of the
pathogenesis of insulin resistance and T2DM.

TABLE OF CONTENTS

Abstract

Introduction
Background

1

Insulin Resistance and Lipid Compartments

3

Ethnic Differences in Fat Distribution

6

Statement of Purpose

7

Methods
Participants

9

Metabolic Studies

9

Imaging Studies

11

Analytical Procedures and Calculations

12

Statistical Analysis

13

Results
Anthropometric Characteristics of the Cohort

14

Metabolic Profile of the Cohort

14

Muscle and Abdominal Lipid Partitioning

17

Relationships between Lipid Partitioning and Insulin Sensitivity

20

Discussion

23

References

29

1
INTRODUCTION

Background
Childhood obesity has reached epidemic proportions and is a paramount public
health concern. During the past 30 years, the number of children diagnosed as being
overweight has more than doubled.1 The 1999-2002 National Health and Nutrition
Examination Survey (NHANES) data indicate that, among children aged 6 through 19
years in 1999-2002, nearly one third (31.0%) were “at risk for overweight”—defined by a
body mass index (BMI) between the 85th and 95th percentiles for age—and 16.0% were
overweight—defined as a BMI of 95th percentile for age.2 In contrast, between 1988
and 1994 (NHANES III), approximately 11% of children and adolescents were
overweight and 14% had a BMI between the 85th and 95th percentiles.3 The prevalence
of overweight children and adolescents in 2002 (16%) was more than three times the
expected prevalence based on prior surveys (5%).2 Children from racial minority groups
are affected disproportionately. Among non-Hispanic black, and Mexican-American
children and adolescents, 20.5% and 22.1%, respectively, are overweight, compared with
13.6% among non-Hispanic white children and adolescents.2 Similar increases in the
prevalence of obesity have been observed worldwide.4 Obesity in children is an
important early risk factor for much of adult morbidity and also accounts for many
significant health problems in the pediatric population.5
Overweight or obesity is the most important risk factor for the development of
type 2 diabetes mellitus (T2DM) in youth.6 Parallel to the obesity epidemic, the
prevalence of T2DM has increased alarmingly among children worldwide during the past
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decade.7 The incidence of T2DM in children has increased by 10-fold from 1982 to
1994.8 The Centers for Disease Control (CDC) predicts that, if current obesity rates
continue, one in three newborns born in 2000 will eventually develop diabetes.9 In
African-American and Hispanic youth, T2DM is more common than in people of
Caucasian origins.10
Insulin resistance (IR), defined as an inability of target tissues to increase glucose
uptake in response to insulin, is now widely believed to be the first step in the
development of T2DM. In 1988, Reaven and colleagues described “the metabolic
syndrome”—otherwise referred to as “syndrome X” or the “insulin-resistance
syndrome”—as a link between insulin resistance, hypertension, dyslipidemia, T2DM, and
other metabolic abnormalities associated with an increased risk of atherosclerotic
cardiovascular disease in adults.11 According to the NCEP and ATPIII panel, individuals
meeting at least three of the following five criteria qualify as having the metabolic
syndrome: (1) elevated blood pressure, (2) high triglyceride level, (3) low HDLcholesterol level, (4) high fasting glucose, and (5) central obesity. This syndrome affects
approximately 25% of the U.S. adult population, and may be present in as many 30% of
obese adolescents.12, 13 While there are no established criteria for diagnosing the
metabolic syndrome in the pediatric population, in a recent study of 439 obese, 31
overweight, and 20 normal-weight children and adolescents, the metabolic syndrome, as
defined by modified ATP criteria, was present in 39 and 50 percent of the moderately and
severely obese subjects, respectively. This indicates that, among obese children, the
prevalence of the metabolic syndrome is high and increases with worsening obesity.14
Similar to obesity and T2DM, insulin resistance seems to affect children from racial
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minorities disproportionately. The ethnicity-related prevalence of T2DM is attributed to
a greater degree of obesity and severity of insulin resistance.15 Several studies have
demonstrated decreased insulin sensitivity in healthy African-American and Hispanic
children compared with their Caucasian peers.16-18 The reason for these racial differences
have not yet been elucidated.19
The underlying mechanisms relevant to the changes in insulin sensitivity and
secretion in the early stages of diabetes in youth are still largely unknown. Increasing our
understanding of the mechanisms responsible for the insulin resistance associated with
childhood obesity is of utmost importance. The obese pediatric population provides an
interesting opportunity to study early metabolic alterations associated with obesity.
Unlike in children, obesity in adults is usually long lasting. Therefore, the association of
generalized insulin resistance, compensatory hyperinsulinemia, and increased visceral fat
may simply reflect adaptations to long-term obesity rather than a causal relationship.
Also, the model of childhood obesity is free from long-term effects of life-style
conditions, such as smoking, chronic alcohol consumption, and uncontrollable stress,
which are known to strongly influence fat distribution and its metabolic correlates.20

Insulin Resistance and Lipid Compartments
In addition to the association between insulin resistance and generalized obesity,
many studies have revealed associations between insulin resistance and distribution of
body fat. Using non-invasive methods, such as computed tomography (CT)—which
clearly distinguishes fat from other tissues and allows for the measurement of visceral and
subcutaneous abdominal fat—has furthered our understanding of the links among body
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composition and insulin resistance. Visceral fat accumulation is known to be associated
with features of the metabolic syndrome in adults and obese children, although the nature
of this association and the relative importance of visceral and subcutaneous abdominal fat
in the pediatric population remains a matter of debate.21-23 More recently, a different fat
deposit has garnered increased attention as an important contributor to the metabolic
phenotype responsible for insulin resistance.24
Skeletal muscle is the primary site of insulin-stimulated glucose disposal at
euglycemia and, as such, is a major locus of insulin resistance. Among the putative
mechanisms underlying insulin resistance, increased attention has been paid to elevated
circulating levels of free fatty acids (FFAs).25 In 1967 Denton and Randle26 were the
first to describe the existence of lipid storage in muscles. More recently, FFAs derived
from skeletal muscle lipolysis have been recognized as an important endogenous source
of energy in addition to the energy storage in adipose tissue.27 Triglyceride content
measured in muscle biopsies obtained from non-diabetic Pima Indians (an ethnic group
with a pronounced disposition to obesity and T2DM) was found to be related to insulin
resistance, independent of total adiposity.28 Subsequent studies have shown similar
results.29, 30
The putative molecular mechanism responsible for the inverse relationship
between insulin sensitivity and IMCL focuses on the action of free fatty acids and IMCL
metabolites, such as long-chain fatty acyl-CoAs (LCA-CoA), on phosphatidylinositol-3kinase (PI3K).31 PI3K is a key signal transducer in insulin-mediated glucose transport
facilitated by incorporation of GLUT4 transporters into the muscle cell membrane.
Increased plasma FFA and intracellular accumulations of LCA-CoA, as found in obesity,
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can activate isoforms of protein kinase C (PKC), which in turn might lead to
phosphorylation of serine/threonine sites of the insulin receptor and its substrates (IRS),
thereby decreasing their ability to activate PI3K.32, 33
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Figure 1: Increased plasma FFA- and IMCL-related intracellular accumulations of LCA-CoA
activate isoforms of protein kinase C (PKC), which in turn lead to phosphorylation of
serine/threonine sites of the insulin receptor and its substrates (IRS), thereby decreasing their
ability to activate PI3K and inhibiting GLUT4-dependent glucose import.

Until recently, muscle fat deposits were either measured by muscle biopsy or
estimated by computed tomography. These techniques are incapable of accurately
differentiating between intramyocellular (IMCL) and extramyocellular (EMCL) lipid
content.34 Moreover, the invasive nature of muscle biopsy and the relatively high dose of
ionizing radiation of CT make these techniques unsafe to perform on the pediatric
population. These problems have been overcome by the use of 1H nuclear magnetic
resonance (NMR) spectroscopy.35 This technique has been shown to be capable of
differentiating between IMCL and EMCL 34, as demonstrated in patients with congenital
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lipodystrophy who do not have EMCL content.36 In 1999 Shulman and his group showed
a negative correlation between IMCL concentration, as assessed by localized 1H-NMR
spectroscopy, and whole body insulin sensitivity.37
This noninvasive and safe technique allowed for the determination of IMCL and
EMCL levels in the pediatric population. In the first such study in children by Sinha et
al., both IMCL and EMCL in the soleus muscle were observed to be greater in obese vs.
non-obese adolescents. Moreover, they demonstrated a significant correlation between
intracellular lipid and insulin sensitivity independent of total body fat.38 Weiss et al.—
also using NMR—found an excessive accumulation of IMCL in the soleus muscle of
obese adolescents with impaired glucose tolerance (IGT) compared to age- and adipositymatched obese adolescents with normal glucose tolerance (NGT).39

Ethnic Differences in Fat Distribution
Recently, in an attempt to explain the greater severity of insulin resistance among
minorities, numerous studies have analyzed racial differences in regional fat distribution.
Paradoxically, it has been found that, despite the correlation between visceral fat
accumulation and insulin resistance, African-American children have significantly lower
levels of visceral fat than their Caucasian peers.40, 41 Bacha et al.22 demonstrated that
visceral adiposity has a different impact on the metabolic profile of black obese
adolescents when compared to well matched white adolescents. However, differences in
visceral fat were not able to explain the more diabetogenic insulin sensitivity profile
observed in African Americans. The failure of visceral or subcutaneous adipose tissue to
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explain the ethnic difference in insulin sensitivity suggests that the accumulation of lipid
in other deposits may account for this variation.
Ama et al.42 reported an increased expression of type II muscle fibers in AfricanAmerican sedentary adult men compared to Caucasians. More recently, similar results
were found when comparing obese black and white women, and it was also shown that an
over-expression of type II fibers contribute to the pathophysiology of obesity. 43, 44 Type
II muscle fibers are deficient in oxidative capacity, particularly in relation to lipid
disposal, and an abundance of these fibers can thereby result in the partitioning of lipid
toward storage in skeletal muscle, rather than oxidation within the muscle, leading to a
positive fat balance, fat mass gain and marked insulin resistance.45
There are no studies in the pediatric population that have examined the role of
muscle fiber composition and its relation to obesity and insulin resistance. It is also
unknown whether the racial differences observed with regard to muscle fiber composition
are already present in childhood or adolescence. 1H-NMR spectroscopy of skeletal
muscle is a practical method of accurately assessing the lipid content of that compartment
in children and adolescents and thereby ascertaining whether there are racial differences
in skeletal muscle composition that can be correlated to the differences in insulin
sensitivity.

Statement of Purpose
To determine whether ethnic differences in insulin sensitivity are related to a
greater intramyocellular accumulation of lipid content in obese adolescents of AfricanAmerican and Hispanic origins compared to Caucasian adolescents closely matched for
overall adiposity. 1H-NMR was used to non-invasively quantify IMCL and EMCL in

8
African-American, Hispanic, and Caucasian obese adolescents. Insulin sensitivity was
ascertained by oral glucose tolerance tests (OGTT) in all subjects and the euglycemichyperinsulinemic clamp in a subset of subjects.
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METHODS
Participants
We studied three well matched groups of subjects: 21 overweight AfricanAmerican adolescents, 30 overweight Caucasian adolescents, and 31 overweight
Hispanic adolescents. They were recruited from a multi-ethnic cohort of obese children
and adolescents drawn from the Pediatric Obesity Clinic at Yale-New Haven Hospital.46
To be eligible for this study, they had to be between 8 and 21 years of age, overweight or
obese, (BMI Z-score >1.5), to be taking no medications that can alter glucose
metabolism, and to be otherwise healthy. In all participants we did a complete physical
examination and took a detailed medical history. Ethnicity was determined by self-report
and was based on all four grandparents being of the same ethnic group as the child in the
study. The study was approved by the Human Investigational Committee of the Yale
School of Medicine. Written informed consent was obtained from the parents, and
written assent was given by the participants.

Metabolic Studies
Oral Glucose Tolerance Test (OGTT):
All subjects underwent an OGTT; the subjects consumed a diet containing at least
250 g of carbohydrates per day for three days before the study and refrained from
vigorous physical activity. They were evaluated at 8 a.m., after a 12-hour, overnight fast.
Their weight and height were measured, and their BMI was calculated. Baseline blood
samples were obtained from subjects while they were fasting, with the use of an
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indwelling venous line for measurement of levels of glucose, insulin, lipids, adiponectin,
leptin, and C-reactive protein. An oral glucose-tolerance test was then performed with
the administration of 1.75 g of glucose per kilogram of body weight (maximal dose, 75
g).46

Euglycemic Clamp:
In 47 patients whole-body insulin sensitivity was measured by a two-step
euglycemic clamp.47 The subjects were instructed by a registered dietitian to follow a
weight maintenance diet consisting of at least 250 g carbohydrate per day for 7 days
before the study and to refrain from physical activity. The children arrived at the Yale
Children's Clinical Research Center at 7:30 a.m. after an overnight fast of 10-12 h. Two
intravenous catheters—one for blood sampling and one for infusion of glucose, insulin,
and tracers—were inserted, one in the antecubital vein of each arm after local infiltration
with lidocaine. The arm used for blood sampling was kept in a heated box for
arterialisation of blood. Whole-body insulin sensitivity was measured by a two-step
euglycemic clamp by infusing insulin as a primed continuous infusion at 8 mU m−2 min−1
and 80 mU m−2 min−1. Each step lasted 2 h. A primed-continuous infusion of 6,6deuterium-labelled glucose at a rate of 11·11 μmoles m−2 min−1 and a continuous infusion
of 2H5-glycerol at a rate of 0·21 μmoles m−2 min−1, were used to quantify insulin’s effects
on glucose and glycerol turnover. To maintain the plasma enrichment of 2H-glucose
constant at baseline value throughout the clamp, we used the Hot GINF method.48
Arterialised blood samples were collected every 5-10 min during the last 30 min of the
baseline period and during each insulin infusion period for measurement of glucose and
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glycerol enrichments, hormones, and substrates. Indirect calorimetry was used at
baseline and during the last 30 min of each step of the clamp to estimate net rates of
carbohydrate and lipid oxidation. Non-oxidative glucose metabolism was calculated by
subtracting the amount of glucose oxidized from the whole-body glucose uptake.39
Insulin sensitivity (M) was determined by milligrams glucose uptake per kilogram per
minute and expressed as M/lean body mass (Mlbm).
Imaging Studies
1

H-NMR Spectroscopy:

Localized 1H-NMR spectra of the soleus muscle were acquired on a 2.1 T Biospec
system (Bruker Instruments, Inc, Billerica, MA, USA).38 The clinical status of the
participants was concealed from the investigator who collected and analyzed the data.
All participants were instructed not to undertake any physical activity for 7 days before
the test. All 82 subjects underwent this study.
MRI:
Abdominal MRI studies were performed on a Siemens Sonata 1.5-Tesla system.
The pulse sequence was a T1-weighted Fast Low Angle Shot Gradent Echo (FLASH).
Slices were acquired using a 400cm field of view (TE:4.76, TR:100, 4 excitations, 90°
flip angle, matrix: 256x128, bandwidth:140). The mid-axial section was positioned to
pass through the L4/L5 disc space. Images were imported into the Yale Bioimage Suite
software package.20 Visceral, subcutaneous, deep subcutaneous, and superficial
subcutaneous fat areas were determined. Thresholding was applied to separate fat from
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soft tissue. This procedure was done in 75 of the participants (29 Caucasian, 21 AfricanAmerican, and 25 Hispanic).
DEXA:
Total body composition was measured by dual-energy X-ray absorptiometry with
a Hologic scanner (Boston, MA, USA). The clinical status of the participants was
concealed from the investigator who collected and analyzed these data.
Analytical Procedures and Calculations
Plasma and urine glucose concentrations were measured by the glucose oxidase
method with a glucose analyzer (Beckman Instruments, Brea, CA, USA). Plasma insulin,
C-peptide, leptin, and adiponectin concentrations were measured by double-antibody
radioimmunoassays. Plasma fatty acids were assayed by a colorimetric method.
Analysis of enrichments of 2H-glucose and 2H5 -glycerol in plasma and infusates by gas
chromatography and mass spectrometry was done as described elsewhere.49
Parameters reflecting insulin sensitivity were derived from the OGTT. Estimated
insulin sensitivity was calculated using the Matsuda index50 (whole-body insulin
sensitivity index [WBISI]), which has been validated by comparison with euglycemichyperinsulinemic clamp studies in obese children and adolescents.51 The index was
calculated according to the following formula:
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During the insulin clamp study, the amount of glucose required to maintain
euglycemia provides an index of insulin-stimulated glucose metabolism. The glucose
infusion rates were calculated during the last 30 min of the low and high insulin clamp
and expressed as μmol glucose per kg of lean body mass per min. Endogenous hepatic
glucose production and glycerol turnover at baseline and during the two steps of the
insulin clamp, along with the clamped glucose disposal rates, were calculated as
previously reported.49 In the basal state, we calculated an index of hepatic insulin
resistance as the product of endogenous glucose production and the fasting insulin
concentrations.47, 39
Statistical Analysis
Data are represented as mean ± SD. Parameters that were not normally distributed were
log-transformed for analysis. Multiple pair-wise comparisons of subjects were performed
using ANOVA with post-hoc Holm correction for multiple comparisons between pairs.
Adjustment of comparisons for potential confounders was performed using analysis of
covariance with main effects for age, sex, %fat and other relevant covariates where
appropriate. Pearson or Spearman correlation analysis was used when applicable to
examine bivariate relationships. A p value of <0.05 was considered statistically
significant. All analyses were performed using SAS/STAT for Windows.
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RESULTS
Anthropometric Characteristics of the Cohort
A total of 82 obese children and adolescents (30 Caucasian, 21 African-American,
and 162 Hispanic) participated in this study (Table 1). Fewer boys than girls participated
in the study (12 Caucasian (40%), 9 African-American (43%), and 15 Hispanic (48%)),
but the distribution of sex was not significantly different across race (p = 0.80). The three
groups were similar with regard to age, weight, height, BMI and BMI z-score. Of note,
assessment of whole body composition by DEXA revealed similar percent fat, lean body
mass, and total body fat mass among the three groups.

Metabolic Profile of the Cohort
The metabolic profile of the participants was in most aspects very similar across
race (Table 2). After adjusting for age, sex, and percent body fat, there was no significant
race main effect, or race*sex interaction in fasting glucose and insulin, two-hour glucose,
insulin, and WBISI. A total of 47 subjects (14 Caucasian, 13 African-American, and 20
Hispanic) underwent the euglycemic clamp. As reported in Table 2, there was no
significant race main effect or race*sex interaction in insulin sensitivity (M/lean body
mass). For the lipid profile, total cholesterol, HDL, and LDL were similar. African
Americans had significantly lower triglyceride levels than Hispanics (p = 0.04) and also
lower levels than Caucasians, but this did not reach significance (p = 0.13). Of note,
Hispanics had higher levels of free fatty acids than Caucasians (p = 0.01) and African
Americans (p = 0.01). African Americans had higher levels of leptin than Caucasians (p
= 0.05) and Hispanics (p = 0.02). Adiponectin levels were similar across race.
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Table 1: Anthropometric Characteristics (mean ± SD)
Caucasian

African-American

Hispanic

N

30

21

31

Gender

12 (40%) Male
18 (60%) Female

9 (42.9%) Male
12 (57.1%) Female

15 (48.4%) Male
16 (51.6%) Female

Age (yrs)

14.13 ± 2.15 (10-19)

14.19 ± 2.16 (11-21)

14.16 ± 2.46 (10-21)

Weight (kg)

95.81 ± 20.10 (55.3-194.7)

101.85 ± 18.79 (58.3-135.0)

100.24 ± 20.47 (60.8-136.7)

Height (cm)

164.77 ± 10.09 (150.0-194.7)

165.71 ± 9.46 (147.5-182.0)

163.61 ± 9.78 (142.5-184.0)

BMI (kg/m2)

35.29 ± 6.22 (23.7-50.5)

36.96 ± 5.84 (26.8-46.8)

37.23 ± 5.95 (24.2-51.29)

BMIz

2.27 ± 0.32 (1.47-2.71)

2.39 ± 0.26 (1.90-2.89)

2.43 ± 0.36 (1.57-3.08)

%Fat

40.13 ± 13.12 (27.3-55.1)

39.05 ± 5.06 (26.6-48-6)

40.51 ± 5.16 (26.5-47.4)

Total Fat Mass
(kg)

38.39 ± 13.12 (16.5-76.3)

40.55 ± 10.73 (18.2-61.6)

39.38 ± 9.76 (24.6-62.3)

Lean Body Mass
(kg)

54.21 ±10.84 (32.0-77.9)

58.58 ± 10.22 (38.0-76.9)

56.26 ± 12.13 (37.4-82.3)
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Table 2: Metabolic Profiles (mean ± SD)

Caucasian

African-American

Hispanic

pa

Glucose 0
(mg/dl)

89.8 ± 6.5 (70-102)

92.5 ± 7.1 (76-106)

90.9 ± 6.4 (78-102)

Not significant

Insulin 0
(mg/dl)

30.2 ± 16.5 (8-85)

30.9 ± 13.3 (11-56)

37.8 ± 20.1 (12-97)

Not significant ,

Glucose 120
(mg/dl)

113.9 ± 14.5 (77-133)

112.0±19.0 (72-136)

112.7 ± 20.4 (39-137)

Not significant

Insulin 120
(mg/dl)

143 ± 88 (31-376)

161.7 ± 153.9 (21-624)

191 ± 217 (45-1209)

Not significant ,

WBISI

2.00 ± 0.86 (0.54-3.89)

2.05 ± 1.09 (0.63-4.62)

1.73 ± 1.02 (0.32-4.30)

Not significant ,

Mlbm

0.091 ± 0.047 (0.03-0.17)

0.092 ± 0.046 (0.03-0.21)

0.092 ± 0.053 (0.03-0.22)

Not significant ,

Tot. Chol.
(mg/dl)

158 ± 28 (103-214)

161 ± 40 (99-243)

150 ± 28 (96-218)

Not significant ,

HDL
(mg/dl)

41 ± 9 (23-63)

49 ±12 (33-77)

37 ± 6 (26-51)

Not significant ,

LDL
(mg/dl)

91 ± 27 (47-150)

95 ± 34 (50-188)

89 ± 23 (37-141)

Not significant ,

TG
(mg/dl)

120 ± 81 (15-394)

80 ± 51 (22-263)

117 ± 53 (49-276)

FFA
(meq/dl)

456 ± 125 (150-670)

436 ± 133 (295-800)

570 ± 150 (334-888)

Leptin
(ng/dl)

28.4 ± 16.9 (8-85)

33.6 ± 15.5 (11-67)

27.0 ± 13.9 (6-59)

Adiponectin
(μg/dl)

8.04 ± 4.29 (1.4-18.4)

7.91 ± 3.42 (2.6-14.4)

6.76 ± 3.06 (2.9-16.6)

(mg/kg min)

a

Adjusted for age, sex, and percent fat.
No significant race main effect, or race*sex interaction.
c
Variable log transformed in model due to skewed distribution
b

b

b c

b

bc

bc

bc

bc

bc

bc

C vs. AA: 0.13
C vs. H: not sig.
c
AA vs. H: 0.04
C vs. AA: not sig.
C vs. H: 0.01
c
AA vs. H: 0.01
C vs. AA: 0.05
C vs. H: not sig.
c
AA vs. H: 0.02
bc

Not significant ,
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Muscle and Abdominal Lipid Partitioning
As shown in figure 2, IMCL was significantly higher in the Hispanic group (1.50
± 0.64%) than in the African-American (1.09 ± 0.49%) and the Caucasian (1.19 ± 0.40%)
groups (p = 0.01 and p = 0.04 respectively). The difference between the AfricanAmerican and Caucasian groups was not significant. EMCL levels were not significantly
different between the Caucasian (1.51 ± 0.95%), African-American (1.78 ± 0.95%) and
Hispanic groups (1.91 ± 0.79%) (Figure 3).
Visceral fat was significantly lower in the African-American group (42.7 ±
18.8cm2) than in the Caucasian (70.9 ± 27.5cm2) and the Hispanic (77.3 ± 41.9cm2)
groups (p = 0.0006 and p < 0.0001, respectively) (Figure 4). Subcutaneous fat was
higher in the African-American group (596 ± 186cm2) than in the Caucasian (547 ±
191cm2) and Hispanic (543 ± 160cm2) groups (p = 0.04 and p = 0.06, respectively)
(Figure 5). The Caucasian and Hispanic groups were similar with regards to visceral and
subcutaneous fat.
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Figure 2: IMCL
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Figure 4: Visceral Fat
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Figure 5: Subcutaneous Fat
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Relationships between Lipid Partitioning and Insulin Sensitivity
Pearson correlation analysis revealed a significant relationship between WBISI
and IMCL of the entire cohort (r = -0.27; p = 0.02) (Figure 6). In the subset that
underwent the euglycemic clamp, Mlbm exhibited a similar correlation with IMCL (r = 0.37; p = 0.01). Correlations between WBISI and IMCL within the individual groups did
not reach significance and were not significantly different from each other.
There was also a significant correlation between WBISI and visceral adiposity
when examining the entire cohort (r = -0.38; p = 0.001). (Figure 6). This correlation was
also significant for the Caucasian (r = -0.41; p= 0.03) and Hispanic (r = -0.41; p = 0.04)
groups but not for the African-American group (r = -0.29; p = 0.21). In the subset of the
cohort that underwent the euglycemic clamp, there was a significant correlation between
Mlbm and visceral fat (r = -0.56; p < 0.0001).
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DISCUSSION
Our study is the first to compare IMCL levels—determined by 1H-NMR
spectroscopy—across race in a pediatric population. We also examined racial differences
in the correlation between IMCL levels and insulin sensitivity. Given the higher
incidence of insulin resistance and diabetes in minority populations, we hypothesized that
obese Hispanic and African-American youth would have higher IMCL levels than their
Caucasian counterparts. Our study showed that our hypothesis held true for Hispanics
but not for African Americans. The Hispanic children and adolescents in our study had
significantly higher IMCL levels (after adjusting for age, sex, and percent fat) than their
well-matched Caucasian and African-American counterparts. African-American
children, on the other hand, had the lowest IMCL levels, although the difference between
African Americans and Caucasians did not reach significance.
Our study also reaffirmed that African-American children have very different
composition of their abdominal lipid compartments than their Caucasian and Hispanic
peers. The African-American group in our study had significantly lower visceral fat
deposits and significantly higher subcutaneous fat deposits than the Caucasian and
Hispanic groups. This has already been shown by several other studies.22, 40, 41
Consistent with the lower levels of visceral fat, as Gower et al. have shown17, we found
African Americans to have lower levels of serum triglycerides than Caucasians and
Hispanics. Lower triglyceride levels despite higher levels of insulin resistance among
African Americans have also been described in adults.52, 53
It is possible that factors similar to those that protect African Americans from
accumulating visceral fat41, 54 may also be responsible for their lower IMCL levels.
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However, in our study, while African Americans tended to have lower IMCL levels than
Caucasians, this difference failed to reach significance. It is possible that this is due to
insufficient power, but it may also represent the fact that, with regard to lipid deposits in
myocytes (as opposed to in the abdominal compartment), African Americans are similar
to their Caucasian counterparts. Our study shows that neither increased visceral fat nor
increased IMCL levels are responsible for the higher rates of insulin resistance that have
been observed in the African-American population. Of note, despite their lower visceral
fat and lower IMCL levels, African Americans in our study had similar levels of insulin
resistance to the other groups. It seems clear that the fat compartments we analyzed are
not directly responsible for the insulin resistance observed in African Americans. It is
likely that either a different lipid compartment has a stronger role in the development of
insulin resistance in African Americans, or perhaps that the pathogenesis of insulin
resistance and T2DM in African Americans is less closely linked to the absolute amount
of adipose tissue in any compartment.
In Hispanics, on the other hand, IMCL levels were significantly higher than in the
other groups. This indicates that Hispanics have a higher propensity to distribute excess
body fat in the muscle compartment than Caucasians and African Americans. Similar
racial differences have been observed in the occurrence of nonalcoholic fatty liver disease
(NAFLD). A recent population-based study of obese adolescents found that NAFLD is
more common in Hispanics than in Caucasians, and is the least common in African
Americans.55 It is unclear why Hispanics are more susceptible to lipid accumulation in
their liver and muscle compartments. It may be due to genetic differences in metabolic
processing and storage of excess fat, but could also be secondary to
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environmental/cultural differences such as diet and exercise. It is very likely that the
increased susceptibility of Hispanics to deposit lipid in the muscle compartment plays an
important role in their increased risk of developing insulin resistance, T2DM, and other
metabolic dysfunction. In accordance with this are the significantly higher levels of
plasma free fatty acids we found in Hispanics as compared to Caucasians and African
Americans. These elevated levels of free fatty acids may be important factors in the
development of increased IMCL levels, which in turn may potentiate and perpetuate the
elevated flux of free fatty acids, and thereby contribute to the deregulation of glucose
metabolism in the pathogenesis of insulin resistance.56, 57
Interestingly, while several studies have shown that African-American and
Hispanic adolescents are more insulin resistant than Caucasian adolescents 17, in our
study insulin sensitivity as measured by the OGTT and the euglycemic clamp (in a subset
of 47 subjects) was very similar between the three groups. However, this finding is not
surprising considering that our study consisted of a very homogenous obese group that
did not include any leans. Bacha et al 22 made a similar observation when comparing
insulin sensitivity between Caucasian and African-American obese adolescents, ascribing
the similarity in insulin sensitivity to the overriding effect of obesity-related insulin
resistance that masked race-related differences in insulin sensitivity.
When looking at the relationship between IMCL levels and insulin sensitivity in
the entire cohort, our study showed an inverse relationship between IMCL levels and
insulin sensitivity. This inverse relationship has already been shown elsewhere.37, 39
When looking at the correlation between IMCL and WBISI within each group, the
correlations did not reach significance. However, the trend seems to imply an inverse
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relationship in the Caucasian and Hispanic group, whereas in the African-American
group, there does not seem to be a clear relationship between the two variables (see
Figure 6). Similarly, when looking at the relationship between visceral fat and insulin
sensitivity of the entire cohort, we again confirmed the inverse relationship between the
two variables. For visceral fat, this inverse relationship was significant for the Caucasian
and Hispanic but not for the African-American group (see Figure 7). However, the
difference in correlations among the ethnic groups again did not reach significance. Our
observations support the above proposed theory that, while lipid deposits in the visceral
and myocellular compartments seem to play important roles in the pathogenesis of insulin
resistance in both Caucasians and Hispanics, they do not appear to have the same
relationship in African Americans. Adequately powered studies are warranted to address
this important issue.
While our study would have benefited from a larger sample size, its strength lies
in the robustness of our methods. 1H-NMR spectroscopy of the soleus muscle is
currently the gold standard for determining IMCL levels in children and adults. We used
MRI to analyze the abdominal fat compartment, and DEXA for the assessment of total
body fat, LBM, and percent fat. A large subset of our subjects underwent the euglycemic
clamp, while all subjects had OGTTs for the assessment of insulin sensitivity. We
included only NGTs in our study to ensure that our subjects were well matched with
respect to their metabolic profiles. Our groups were very well matched with respect to
most anthropometric variables (see Table 1); as mentioned above, we had relatively more
boys in the Hispanic group, but this difference was not significant. The robust nature of
our methods required a large time commitment from our subjects and therefore limited
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the number of subjects we were able to enroll. The other limitation of our current study
is that our cohort consisted mainly of extremely obese subjects without the inclusion of
overweight or lean subjects. With a well matched cohort representing the entire spectrum
of adiposity, from lean to very obese, we perhaps would have been able to bring out the
differences in insulin sensitivity that have been observed among the different ethnic
groups and potentially single out the importance of IMCL in the pathogenesis of insulin
resistance.
In conclusion, in a cohort of obese children and adolescents, we demonstrated that
Hispanics have higher IMCL levels and plasma free fatty acids than do Caucasians and
African Americans. The IMCL levels of African Americans tended to be lower than
those of Caucasians but not significantly different. Visceral fat and plasma triglycerides
were significantly lower in African Americans and were similar in Caucasians and
Hispanics. The three groups were not different with respect to insulin sensitivity. The
inverse relationship between IMCL levels and insulin sensitivity held true for the entire
cohort but did not reach significance in the individual ethnic groups. The correlation
between high IMCL levels and insulin resistance seemed to be stronger in Hispanics and
Caucasians than in African Americans, but our study did not have sufficient power to
elucidate this. We also confirmed the correlation between visceral fat and insulin
resistance in Hispanics and Caucasians but not in African Americans. In addition, our
data raises several important questions to be answered in subsequent studies. We showed
that, in the Hispanic population, intramyocellular lipid may be an important mediator and
marker for insulin resistance. The mechanism that predisposes Hispanics to deposit
higher levels of lipid in this compartment than their peers in other ethnic groups needs to
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be further elucidated. We also need to further our understanding of the mechanism by
which high IMCL levels contribute to the pathogenesis of insulin resistance and T2DM.
On the other hand, we need to understand by what mechanism African Americans
prevent lipid deposition in the abdominal and muscle compartment and why they are
nevertheless at a higher risk of developing insulin resistance and T2DM compared to
Caucasians. Further molecular analysis and detailed metabolic studies supplemented by
imaging in large cohorts of lean and obese children will be necessary to answer these
important questions.
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